Other studies show that VPA inhibits SOD1 activity and thus serves as a mechanism by which VPA exposure increases ROS availability and alters intracellular redox states and may promote the development of VPA-MetS [187]. The gene discussed is SOD1; the disease is metabolic syndrome.